These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 16997910
1. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Lambert JD, Sang S, Hong J, Kwon SJ, Lee MJ, Ho CT, Yang CS. Drug Metab Dispos; 2006 Dec; 34(12):2111-6. PubMed ID: 16997910 [Abstract] [Full Text] [Related]
2. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995 [Abstract] [Full Text] [Related]
3. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. Cancer Epidemiol Biomarkers Prev; 2001 Jan 08; 10(1):53-8. PubMed ID: 11205489 [Abstract] [Full Text] [Related]
4. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. Chiou YS, Ma NJ, Sang S, Ho CT, Wang YJ, Pan MH. J Agric Food Chem; 2012 Apr 04; 60(13):3441-51. PubMed ID: 22409325 [Abstract] [Full Text] [Related]
5. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice. Lambert JD, Kim DH, Zheng R, Yang CS. J Pharm Pharmacol; 2006 May 04; 58(5):599-604. PubMed ID: 16640828 [Abstract] [Full Text] [Related]
6. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity. Isbrucker RA, Bausch J, Edwards JA, Wolz E. Food Chem Toxicol; 2006 May 04; 44(5):626-35. PubMed ID: 16364532 [Abstract] [Full Text] [Related]
7. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors. Chiou YS, Sang S, Cheng KH, Ho CT, Wang YJ, Pan MH. Carcinogenesis; 2013 Jun 04; 34(6):1315-22. PubMed ID: 23385063 [Abstract] [Full Text] [Related]
8. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Zhang ZM, Yang XY, Yuan JH, Sun ZY, Li YQ. Chin Med J (Engl); 2009 Jul 20; 122(14):1660-5. PubMed ID: 19719968 [Abstract] [Full Text] [Related]
9. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. Rieger-Christ KM, Hanley R, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, Yee AS, Le SM, Marie PJ, Libertino JA, Summerhayes IC. J Cell Biochem; 2007 Oct 01; 102(2):377-88. PubMed ID: 17348027 [Abstract] [Full Text] [Related]
10. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP. Cancer Res; 2007 May 01; 67(9):4303-10. PubMed ID: 17483343 [Abstract] [Full Text] [Related]
11. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate. Lambert JD, Kwon SJ, Ju J, Bose M, Lee MJ, Hong J, Hao X, Yang CS. Carcinogenesis; 2008 Oct 01; 29(10):2019-24. PubMed ID: 18684728 [Abstract] [Full Text] [Related]
12. Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells. Waleh NS, Chao WR, Bensari A, Zaveri NT. Anticancer Res; 2005 Oct 01; 25(1A):397-402. PubMed ID: 15816564 [Abstract] [Full Text] [Related]
13. Potent effects of peracetylated (-)-epigallocatechin-3-gallate against hydrogen peroxide-induced damage in human epidermal melanocytes via attenuation of oxidative stress and apoptosis. Ning W, Wang S, Liu D, Fu L, Jin R, Xu A. Clin Exp Dermatol; 2016 Aug 01; 41(6):616-24. PubMed ID: 27339454 [Abstract] [Full Text] [Related]
14. Enhanced antitumor activities of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives in vitro and in vivo. Matsumura K, Kaihatsu K, Mori S, Cho HH, Kato N, Hyon SH. Biochem Biophys Res Commun; 2008 Dec 26; 377(4):1118-22. PubMed ID: 18983978 [Abstract] [Full Text] [Related]
15. Immune cell activation and subsequent epithelial dysfunction by Staphylococcus enterotoxin B is attenuated by the green tea polyphenol (-)-epigallocatechin gallate. Watson JL, Vicario M, Wang A, Moreto M, McKay DM. Cell Immunol; 2005 Sep 26; 237(1):7-16. PubMed ID: 16213476 [Abstract] [Full Text] [Related]
16. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. Landis-Piwowar KR, Wan SB, Wiegand RA, Kuhn DJ, Chan TH, Dou QP. J Cell Physiol; 2007 Oct 26; 213(1):252-60. PubMed ID: 17477351 [Abstract] [Full Text] [Related]
17. Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Lambert JD, Rice JE, Hong J, Hou Z, Yang CS. Bioorg Med Chem Lett; 2005 Feb 15; 15(4):873-6. PubMed ID: 15686878 [Abstract] [Full Text] [Related]
18. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. Jin YR, Im JH, Park ES, Cho MR, Han XH, Lee JJ, Lim Y, Kim TJ, Yun YP. J Cardiovasc Pharmacol; 2008 Jan 15; 51(1):45-54. PubMed ID: 18209568 [Abstract] [Full Text] [Related]
19. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME. Int J Oncol; 2007 Oct 15; 31(4):705-11. PubMed ID: 17786300 [Abstract] [Full Text] [Related]
20. Inhibitory effects of (-)-epigallocatechin-3-gallate from green tea on the growth of Babesia parasites. Aboulaila M, Yokoyama N, Igarashi I. Parasitology; 2010 Apr 15; 137(5):785-91. PubMed ID: 20025823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]